- Home
- LMFA vs SNSE Comparison
LMFA vs SNSE Comparison
Compare LMFA & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- SNSE
- Stock Information
- Founded
- LMFA 2008
- SNSE 2005
- Country
- LMFA United States
- SNSE United States
- Employees
- LMFA N/A
- SNSE N/A
- Industry
- LMFA Finance: Consumer Services
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- LMFA Finance
- SNSE Health Care
- Exchange
- LMFA Nasdaq
- SNSE Nasdaq
- Market Cap
- LMFA 8.6M
- SNSE 9.3M
- IPO Year
- LMFA 2015
- SNSE 2021
- Fundamental
- Price
- LMFA $2.36
- SNSE $8.69
- Analyst Decision
- LMFA Hold
- SNSE Strong Buy
- Analyst Count
- LMFA 1
- SNSE 3
- Target Price
- LMFA N/A
- SNSE $86.67
- AVG Volume (30 Days)
- LMFA 104.2K
- SNSE 12.2K
- Earning Date
- LMFA 08-13-2025
- SNSE 08-05-2025
- Dividend Yield
- LMFA N/A
- SNSE N/A
- EPS Growth
- LMFA N/A
- SNSE N/A
- EPS
- LMFA N/A
- SNSE N/A
- Revenue
- LMFA $8,029,601.00
- SNSE N/A
- Revenue This Year
- LMFA $0.98
- SNSE N/A
- Revenue Next Year
- LMFA $4.31
- SNSE N/A
- P/E Ratio
- LMFA N/A
- SNSE N/A
- Revenue Growth
- LMFA N/A
- SNSE N/A
- 52 Week Low
- LMFA $1.02
- SNSE $5.00
- 52 Week High
- LMFA $5.35
- SNSE $17.40
- Technical
- Relative Strength Index (RSI)
- LMFA 67.15
- SNSE 63.87
- Support Level
- LMFA $1.62
- SNSE $5.86
- Resistance Level
- LMFA $2.46
- SNSE $8.74
- Average True Range (ATR)
- LMFA 0.18
- SNSE 0.75
- MACD
- LMFA 0.05
- SNSE 0.25
- Stochastic Oscillator
- LMFA 82.74
- SNSE 88.54
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).